loader from loading.io

Inside the class-action lawsuit against insulin pricing, with Attorney Steve Berman

Diabetes Connections | Type 1 Diabetes

Release Date: 05/14/2024

Navigating the insurance maze with T1D - consultant (and D-Mom) Emily Adams show art Navigating the insurance maze with T1D - consultant (and D-Mom) Emily Adams

Diabetes Connections | Type 1 Diabetes

This week, I think it’s fair to say that we all struggle with insurance issues. Diabetes – or any chronic condition – increases the hoops we jump through, the expense and the stress. I’m talking to Emily Adams an employee benefits consultant to get some advice about how to navigate. Emily thought she knew the system pretty well, but then her daughter was diagnosed with type 1 and she learned on a personal level how complex our system is. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Find out more...

info_outline
My son was diagnosed with T1D at age two. How was his first year away at college? show art My son was diagnosed with T1D at age two. How was his first year away at college?

Diabetes Connections | Type 1 Diabetes

When my son was diagnosed with type 1 more than 17 years ago, the day he’d leave home seemed very far away, but also something we knew we needed to plan for. Well, Benny finished his Freshman year of college – he goes to school 300 miles away – and he’s here to talk about it. We answer your questions about how it went, how he managed, how I managed and what’s next. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Previous Previous Find out more about  Please visit our Sponsors & Partners - they...

info_outline
In the News... Generic GLP-1, All-in-one sensor and infusion set, 365-day CGM, T1D & Roblox and more! show art In the News... Generic GLP-1, All-in-one sensor and infusion set, 365-day CGM, T1D & Roblox and more!

Diabetes Connections | Type 1 Diabetes

It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: The Eversense CGM could soon be approved for one year of continuous use, the first generic GLP-1 medication is launched, a new company tauts and all-in-one sensor and pump infusion set, a new diabetes accessory in the Roblox game, and more! Find out more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures Learn more about Drive The best way to keep up with Stacey and the show is by signing up for our...

info_outline
Dexcom updates from ADA 2024 with CEO Kevin Sayer show art Dexcom updates from ADA 2024 with CEO Kevin Sayer

Diabetes Connections | Type 1 Diabetes

Stacey sits down with Dexcom’s CEO for an in-person interview at ADA Scientific Sessions. Dexcom made a little bit of news at the conference, but it’s a less-trumpeted replacement policy that had you all asking a lot of questions. We’ll go through the latest news, updates, sensor issues, and a peek into the future with Dexcom’s CEO Kevin Sayer. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Find out more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more...

info_outline
What is EPI? DIY diabetes pioneer  Dana Lewis wants you to know your risk show art What is EPI? DIY diabetes pioneer Dana Lewis wants you to know your risk

Diabetes Connections | Type 1 Diabetes

DIY Pioneer Dana Lewis was diagnosed with something called EPI – exocrine pancreatic insufficiency a couple of years ago. She’d never heard of it and was shocked to find out diabetes is considered a common co-condition. In fact, 20-30 percent of people with diabetes can end up with EPI. EPI can cause a lot of discomfort and stomach issues – and health issues if left untreated. Of course, Dana jumped in, publishing a review of studies and now- creating studies of her own. She’ll explain what she’s doing, why she needs your help, and more about this condition that doesn’t get much...

info_outline
In the news.. Insulin pen shortage, Omnipod 5 update, once-weekly insulin approved in Canada, and more! show art In the news.. Insulin pen shortage, Omnipod 5 update, once-weekly insulin approved in Canada, and more!

Diabetes Connections | Type 1 Diabetes

It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: South Africa runs out of insulin pens - and why this could happen anywhere, once-weekly insulin is approved in Canada, update on Omnipod 5 with Dexcom G7 rollout, more older people are getting type 1 but more people are living longer with it, CGM at the Olympcs and more! Find out more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures Learn more about Drive The best way to keep up with Stacey and the...

info_outline
The business of diabetes - Scott Strumello's perspective after 50 years of T1D show art The business of diabetes - Scott Strumello's perspective after 50 years of T1D

Diabetes Connections | Type 1 Diabetes

Scott Strumello has lived almost 50 years with type 1. Diagnosed as a child in the 70s, he found the online community and started blogging. Scott has a unique perspective – with a background in finance and consulting, he’s a reliable source of what’s happening in earnings calls, legislation, and the business of diabetes. We have a great talk about what’s coming in terms of biosimilars, the role of PBMs and some legal action that may happen this year.   This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider....

info_outline
JDRF is now “Breakthrough T1D” - Behind the rebrand (and other changes) show art JDRF is now “Breakthrough T1D” - Behind the rebrand (and other changes)

Diabetes Connections | Type 1 Diabetes

JDRF… is no more. A rebranding and name change means the organization founded in 1970 by concerned parents will now be known as Breakthrough T1D. You can guess some of the reasons for this change – the “J” for juvenile has long been a turn off for adults living with type 1 – but some of the other reasons are surprising. We’ll do a deep dive into what this means for the community, the fund raising and research, and the organization itself. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Stacey's The...

info_outline
In the News... Dexcom to Apple Watch, Metformin during pregnancy, Mounjaro shortage update... and more! show art In the News... Dexcom to Apple Watch, Metformin during pregnancy, Mounjaro shortage update... and more!

Diabetes Connections | Type 1 Diabetes

It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: Dexcom goes Direct to Watch in the US, Abbott gets FDA okay for its OTC CGM, new study about metformin during pregnancy, an update on semaglutides, JDRF changes its name, and more! Find out more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures Learn more about Drive The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Here's where to find us: Learn more...

info_outline
How close are we to glucose-responsive insulin?  An update from Sensulin’s CEO show art How close are we to glucose-responsive insulin? An update from Sensulin’s CEO

Diabetes Connections | Type 1 Diabetes

We’ve been hearing about smart insulin for a long time. This refers to an insulin that would react to glucose levels and adjust by itself with no external device, like a CGM, needed. You’d inject and let the insulin do the work. I’m talking to Sensulin CEO Mike Moradi about where their version of this amazing sounding technology stands, his family connections that really feeds his passion here, and what has to happen to get glucose-responsive insulin into the hands of people who could benefit.   This podcast is not intended as medical advice. If you have those kinds of...

info_outline
 
More Episodes

This week, talking with one of the lawyers bringing a class-action lawsuit against the insulin companies.. a lawsuit that has been inching forward since 2017. It was set to be settled for 500-million dollars and a four year price cap, but then judge said no.  Attorney Steve Berman will talk about that last minute surprise, why he’s still going forward, and  what he needs now from the diabetes community.

This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.

My guest is Attorney Steven Berman from the firm Hagens (Haagens like Haagen Daas) Berman. Steve co-founded Hagens Berman in 1993 after his prior firm refused a fast food e coli case. That turned out to be the famous case against Jack in the Box, which resulted in a class action settlement and changed many food safety laws. He’s also been involved in cases against Big Tobacco and, as you’ll hear, other medical pricing lawsuits.  

Learn more about the case and fill out the form to see if you're entitled to compensation here: https://www.hbsslaw.com/cases/insulin-overpricing#block-form-block-destination

Find out more about Moms' Night Out - registration is open for Denver!

Please visit our Sponsors & Partners - they help make the show possible!

Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com)

Omnipod - Simplify Life

Learn about Dexcom 

Edgepark Medical Supplies

Check out VIVI Cap to protect your insulin from extreme temperatures

Learn more about AG1 from Athletic Greens 

Drive research that matters through the T1D Exchange

The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:

Sign up for our newsletter here

Here's where to find us:

Facebook (Group)

Facebook (Page)

Instagram

Twitter

Check out Stacey's books!

Learn more about everything at our home page www.diabetes-connections.com 

Reach out with questions or comments: [email protected]